UNFPA
12th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicine Request for EOI

Reference: UNFPA/DNK/EOI/17/030
Beneficiary countries: Multiple destinations (see 'Countries' tab below)
Published on: 29-Sep-2017
Deadline on: 15-Nov-2017 17:00 (GMT 1.00) Brussels, Copenhagen, Madrid, Paris

Description

12th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicines 29 September 2017

The ERP/RHM is an independent technical body composed of external technical experts and hosted by the Unit of Regulation of Medicines and other Health Technologies (RHT) of WHO Department of Essential Medicines and Health Products (WHO/EMP/RHT). The Procurement Services Branch of UNFPA (UNFPA/PSB) provides the Secretariat for the ERP/RHM. The ERP/RHM will be convened by WHO/EMP/RHT and review product dossiers submitted by manufacturers of FPPs that are not yet WHO-prequalified or SRA-authorized, undertake a quality risk analysis associated with the use of those products and provide written advice to the Secretariat to help making evidence based procurement decisions.

All submissions must reach the UNFPA reception in Copenhagen by Thursday, 15 November 2017, at 17.00h (Copenhagen time).